Membranous Nephropathy Associated with the Relatively Selective Cyclooxygenase-2 Inhibitor, Etodolac, in a Patient with Early Rheumatoid Arthritis
Open Access
- 1 January 2007
- journal article
- case report
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 46 (13) , 1055-1058
Abstract
Renal dysfunction and urinary abnormalities, which are usually related to drug toxicity, secondary amyloidosis, or those which overlap with other autoimmune conditions, are frequently observed in patients with rheumatoid arthritis. This is the first case report of membranous nephropathy in a patient with early-stage rheumatoid arthritis treated with the relatively selective cyclooxygenase-2 inhibitor, etodolac. The present case suggests that any kind of non-steroidal anti-inflammatory drug can cause membranous nephropathy; thus, physicians should be aware of this renal toxicity when prescribing these drugs.Keywords
This publication has 10 references indexed in Scilit:
- Early prediction of rheumatoid arthritis by serological variables and magnetic resonance imaging of the wrists and finger joints: results from prospective clinical examinationAnnals of the Rheumatic Diseases, 2006
- Cyclooxygenase-2 inhibitor-associated minimal-change diseaseClinical Nephrology, 2005
- Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxibClinical Nephrology, 2003
- Nephrotic syndrome and interstitial nephritis associated with celecoxibAmerican Journal of Kidney Diseases, 2002
- Renal involvement in rheumatoid arthritis: analysis of renal biopsy specimens from 100 patientsModern Rheumatology, 2002
- Membranous Nephropathy Induced by Treatment with Ampiroxicam, a Nonsteroidal Antiinflammatory DrugNephron, 1999
- Glomerular, tubular and interstitial nephritis associated with non‐steroidal antiinflammatory drugs. Evidence of a common mechanismBritish Journal of Clinical Pharmacology, 1999
- Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugsJAMA, 1996
- Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1European Journal of Pharmacology, 1995
- GLOMERULONEPHRITIS IN RHEUMATOID ARTHRITISRheumatology, 1993